Lesão de isquemia e reperfusão renal: influência da clorpromazina na função renal e na peroxidação lipídica by TUCCI JUNIOR, Silvio et al.
Dias MA et al
42 - Acta Cirúrgica Brasileira - Vol 23 (Supplement 1) 2008
1. Research performed at Department of Surgery and Anatomy, Division of Urology, Ribeirão Preto Faculty of Medicine, University of São
Paulo (USP), Brazil.
8-EXPERIMENTAL RESEARCH
ORIGINAL ARTICLE
Ischemia-Reperfusion
Renal ischemia and reperfusion injury: influence of chorpromazine on renal
function and lipid peroxidation1
Lesão de isquemia e reperfusão renal: influência da clorpromazina  na função renal e na
peroxidação lipídica
Silvio Tucci JuniorI, Roberto Marins de CarvalhoII, Fábia Martins CeliniIII, Adauto José ColognaIV, Haylton Jorge SuaidV,
Luis Fernando TirapelliVI, Antonio Carlos Pereira MartinsVII
ABSTRACT
Purpose: To evaluate the influence of chlorpromazine (CPZ) on renal function and lipid peroxidation in a rat model of
kidney ischemia/reperfusion injury. Methods: Forty eight Wistar rats underwent a laparotomy for hilar clamping of left
kidney with a bulldog clamp for 60 minutes followed by organ reperfusion and contralateral nephrectomy. Of these, 26
received 3mg/kg of CPZ intravenously 15 minutes before renal ischemia (G-E) while the remaining 22 were used as ischemic
control group (G-C). Eleven rats of G-E and 8 of G-C were followed for blood urea nitrogen and creatinine determinations
before renal ischemia and at 1st, 4th and 7th postoperative days. Samplings of left renal tissue were obtained at 5 minutes (5
rats from each group) and 24 hours (9 G-C and 10 of G-E) of reperfusion for malondialdehy (MDA) content determination.
Controls of renal MDA content were determined in kidneys harvested from 6 additional normal rats. Results: Acute renal
failure occurred in all animals but levels of BUN and creatinine were significantly lower in G-E (p<0.001). MDA content rose
strikingly at 5 minutes of reperfusion in both groups (p>0.05) and returned near to normal levels 24 hours later. Conclusion:
CPZ conferred partial protection of renal function to kidneys submitted to ischemia/reperfusion injury that seems to be not
dependent on inhibition of lipid peroxidation.
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RESUMO
Objetivo: avaliar a influência da clorpromazina (CPZ) na função renal e na peroxidação lipídica num modelo de lesão de
isquemia/reperfusão renal em ratos. Métodos: 48 ratos Wistar foram submetidos à laparotomia para clampamento da artéria
renal esquerda durante 60 minutos, seguido da reperfusão e nefrectomia contralateral. Destes animais, 26 receberam 3 mg/
kg de CPZ intravenosa 15 minutos antes da isquemia renal (G-E), sendo os 22 animais restantes utilizados como grupo
controle isquêmico (G-C). Em 11 ratos do G-E e 8 do G-C foi feita a dosagem de uréia e creatinina sérica antes da isquemia
renal e no 1º, 4º e 7º dia pós-operatório. Amostras de tecido do rim esquerdo foram obtidas aos 5 minutos (5 ratos de cada
grupo) e 24 horas após reperfusão (9 G-C e 10 G-E) para dosagem de malondialdeído (MDA). Valores controle para níveis
de MDA foram obtidos em rins retirados de 6 ratos normais. Resultados: insuficiência renal aguda ocorreu em todos os
animais mas os níveis séricos de uréia e creatinina foram significativamente menores no G-E (p<0,001). Os níveis de MDA
apresentaram  elevação acentuada na avaliação aos 5 minutos de reperfusão  em ambos os grupos (p<0,05), retornando a
valores próximos aos normais na avaliação com 24 horas. Conclusão: a CPZ conferiu proteção parcial da função renal aos
rins submetidos à lesão de isquemia e reperfusão, aparentemente independente da inibição da peroxidação lipídica.
Descritores: Isquemia/Reperfusão Renal. Peroxidação Lipídica. Clorpromazina.
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Introduction
Ischemia/reperfusion (I/R) injury is a major cause
of acute renal failure occurring after hemorrhagic shock or
major cardiovascular surgery, and the most common cause
of delayed graft function or organ failure.1,2  Ischemia-
reperfusion injury is a complex phenomenon involving not
only intracellular processes but also an injurious
inflammatory response that are interconnected.3 While the
pathogenesis of ischemia-reperfusion is not completely
understood, there is considerable evidence implicating the
decreased mitochondrial ATP generation, loss of selective
permeability of cell membranes, impairment of  cellular ion
homeostasis (rise of intracellular sodium and calcium) with
activation of hydrolases and accumulation of reactive
oxygen species (ROS) leading to cell injury or death.3-5 ROS
formed during oxidative stress can initiate lipid peroxidation,
oxidize proteins to inactive states and cause DNA strand
breaks, all potentially damaging to normal cellular
function.3,4 Lipid peroxidation is an autocatalytic mechanism
leading to oxidative destruction of cellular membranes, and
their destruction can lead to the production of toxic reactive
aldehydic metabolites and cell death.5-8 A range of drugs
and methods have been tested with the intention to block
the pathways of cell injury at different levels and to thereby
enhance viability of the kidney challenged by ischemia/
reperfusion stress with variable results, such as:  heat shock
(interferes with the L-arginine-nitric oxide pathway),9
antioxidants,10,11 dipyridamole (increases endogenous
adenosine),12,13 nicotine (inhibit cholinergic anti-
inflammatory pathway),14 calcium channel blockers or
antagonists,15-18 chlorpromazine,19,20 etc.  Chorpromazine
(CPZ) is a membrane stabilizer and seems to be able to
preserve mitochondria integrity and to reduce
phospholipids degradation of microsomal membranes of
liver cell provoked by ischemia/reperfusion.20,21 The aim of
our study was to explore the effect of chlorpromazine on
renal function and membrane lipid peroxidation in a rat model
of renal ischemia/reperfusion.
Methods
Forty eight Wistar Rattus novergicus, weighting
200-250g, were anesthetized with an intraperitoneal injection
of thiopental (20mg/kg) and underwent a laparotomy
followed by dissection of the left kidney and hilar clamping
with a bulldog clamp for 60 minutes followed by organ
reperfusion and contralateral nephrectomy. Of these, 26
received 3mg/kg of chlorpromazine intravenously 15 minutes
before renal ischemia (Group E) while the remaining 22 were
used as ischemic control group (Group C). Eleven rats of
Group E and 8 of Group C were followed for blood urea
nitrogen (Urease-Labtest Cat 27®) and creatinine (Creatinine-
Labtest Cat 35®) determination before renal ischemia and in
the 1st, 4th and 7th postoperative days. Samplings of left renal
tissue were obtained at 5 minutes (5 rats from each group)
and 24 hours (9 of Group C and 10 of Group E) of reperfusion
for malondialdehy (MDA) content determination. Normal
controls of renal MDA content were determined in left
kidneys harvested from 6 additional normal rats. For tissue
sampling in the described moments and at the end of
experiment the animals were sacrificed by decapitation.
For the determination of MDA content kidney
samples were homogenized in 9 volumes of Tris-HCl 10mM,
pH 7.4, and centrifuged at 3,000 G for 10 minutes at 4ºC. The
supernatant was aspirated and used to quantify MDA
(expressed in µM) using a lipid peroxidation assay kit
(Calbiochem, cat # 437634, Novobiochem Co, USA) and a
spectrophotometer at absorbance of 586nm.
Statistical analyses were performed with the
software program GraphPad Prism 4 (GraphPad Software
Inc, San Diego, CA). Continuous variables among groups
were compared by Kruskal-Wallis method and Dunn´s
multiple comparisons test as long as their distribution did
not pass the normality test or the differences among the
SDs were very significant. A level of P<0.05 was set as
statistical significant.
Results
The results of blood urea nitrogen (BUN) and
creatinine in groups C and E at different moments of the
experiment are displayed in Tables 1 and 2. In the group C
renal dysfunction lasted till the 7th postoperative day and in
all moments was worse than in group E (p<0.001). In the
group E, creatinine and BUN returned to normal levels on
the 7th postoperative day.
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The mitochondrial MDA content found in normal
kidneys and in kidneys challenged with 60 minutes of
ischemia followed by 5 minutes or 24 hours of reperfusion
is expressed in Table 3. The MDA rose significantly at 5
minutes of reperfusion in both groups of rats, treated or not
with CPZ (p>0.05). Twenty four hours after the ischemic
challenge MDA content tended to return to pre-ischemic
values.
Discussion
Kidneys submitted to warm ischemia during 60
minutes exhibit functional deficit resulting in uremia as
published previously by others.22,23 In the control group
the BUN and creatinine levels remained high till the 7th
postoperative day even though exhibiting a tendency to
return to normal values. In the group treated with CPZ the
levels of BUN and creatinine were lower than in the control
group in the period 1st- 4th days, and at the 7th day their
values return to normal. Thus, CPZ in the dose of 3mg/kg
conferred a partial protection of renal function to kidneys
challenged with warm ischemia for 60 minutes. CPZ ability
to protect tissues against ischemia/reperfusion was reported
by others working with several organs such as: kidney,22,24
liver,19,25 nervous system,26 heart.27 Upon ischemia/
reperfusion challenge, organ depletion of ATP causes
mitochondrial dysfunction, and accumulation of intracellular
sodium, calcium and ROS.4 An associated mechanism of
cell injury is the accelerated rate of phospholipid degradation
in ischemic rat liver tissue, producing a loss of almost one
half the total cellular phospholipid with 3 hours of ischemia,
and pretreatment of the rats with CPZ (20mg/kg) completely
prevented the disturbed phospholipid metabolism at the
same time that it prevented the cell death associated with
as much as 3 hours of ischemia.19,28 Several studies have
also demonstrated that warm ischemia in kidney is
associated with lipid peroxidation that leads to oxidative
destruction of cellular membranes, and their destruction
can lead to the production of toxic, reactive aldehydic
metabolites and cell death.1,7,8 Among the aldehydic
metabolites, MDA and 4-hydroxynonenal are the most
important.29,30 Superficial and deep cortex immunostaining
with antibody against MDA was observed after 30 minutes
of warm renal ischemia and such immunostaining was
observed in the absence of any histological lesions, as
assessed by routine staining; after 45 and 60 minutes of
warm ischemia, lipid peroxidation byproducts were detected
both in the cortex and in the medulla, which is associated
with 33% and 66% of rat deaths respectively.31  Thus the
lipid peroxidation process is involved in kidney damage
during anoxia before reperfusion, and the presence of its
byproducts in renal medulla was associated with the animals’
death.31   Our study confirms that lipid peroxidation occurs
during anoxia since MDA content rose strikingly at 5
minutes of kidney reperfusion and tended to return to normal
values 24 hours later. However, pretreatment of animals with
CPZ, dose of 3mg/kg, was not able to inhibit lipid
peroxidation in our model of renal ischemia which is in
disagreement with the findings reported for ischemic rat
liver.19,28 A possible explanation for such controversy may
be based on the difference of  CPZ dose employed  that was
of 20mg/kg in the model of liver ischemia. The protection of
renal function against ischemia/reperfusion injury promoted
by CPZ at a dosage of 3mg/kg seems to be not related to
inhibition of lipid peroxidation.
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Comments:
In recent years, as pointed by Tucci Jr and colleagues, numerous studies have been conducted on the deleterious effects
of reperfusion following ischemia in different organs including the kidney. Among these studies there are strong evidences
that formation of oxygen-derived free radicals and subsequent lipid peroxidation are implicated as the causative factors of
these injuries. There are many reports about the usefulness of antioxidant drugs as well as the application of methods such
as ischemic preconditioning in the prevention of oxidative stress induced-injury. Also, has been proved that nitric oxide is
involved on the pathophysiology of renal ischemia reperfusion injury, justifying the use of nitric oxide donors as renal
failure complimentary treatment. Chlorpromazine is an alpha-blocker vasodilator widely used in the seventies, to treat renal
failure, but there are few studies taking in account its mechanisms of action concerning lipid peroxidation. One good
study1 refers that chlorpromazine has antioxidant effects, is a putative cellular phospholipase inhibitor and calmodulin
antagonist, blocking the increase in MDA formation. The injury was caused by renal proximal tubule cell death induced by
haloalkene cysteine conjugates. In the present study Tucci Jr and colleagues, using a rat model of renal ischemia reperfusion
injury, chlorpromazine had a protection effect apparently independent of lipid peroxidation, since MDA values are high in
both groups. The study has a good design and, in my opinion, it is possible to speculate if the lipid peroxidation has
different mechanisms according renal injury cause (chlorpromazine blocks the oxidative stress in the haloalkene cysteine
conjugates model and does not block it in case of ischemia reperfusion injury).
1. Groves CE, Lock EA, Schnellmann RG. Role of lipid peroxidation in renal proximal tubule cell death induced by haloalkene
cysteine conjugates.Toxicol Appl Pharmacol. 1991;107:54-62.
Paulo Roberto B. Evora
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Comments:
Studies on the several events occurring during ischemia/reperfusion are certainly important, especially when correlated to
physiopathologic alterations in organ transplants.  In addition, drugs that may “protect” the renal tissue from severe
lesions, which extend kidney regeneration post-transplant, are helpful in clinical applications. In this experimental study,
48 Wistar rats were submitted to renal artery occlusion of one kidney for 60 minutes, followed by contra lateral nephrectomy.
Of these animals, 26 received an endovenous injection of chlorpromazine 15 minutes before renal ischemia by artery
occlusion and the remaining ones were kept as controls. Samples of renal tissue, removed 5 minutes and 24 hours after
perfusion were analyzed for determination of malondialdehyde (to measure lipid peroxidation in the model utilized) Acute
renal failure (ARF) was seen in all animals, but plasma levels of urea and creatinine were lower in the ones  chlorpromazine
treated.  Alterations of malondialdehyde tissue levels were not different in both groups in the study.  It seems that the
partial chlorpromazine protection of renal function in kidneys submitted to the ischemic lesion, is independent of lipid
peroxidation.  Ischemia/reperfusion physiopathology is not completely established, but experimental models like the one
utilized may answer some questions and eventually supply information on the clinical use of drugs as chlorpromazine.
The authors suggest that higher drug dosages may produce different results in the same model.
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MD, PhD, Division of  Nephrology, Department of Clinical Medicine, Ribeirão Preto Faculty of Medicine,  University of
São Paulo, Brazil.
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